(LINE) Lineage, Common Stock - Overview
Sector: Real Estate | Industry: REIT - Industrial | Exchange: NASDAQ (USA) | Market Cap: 8.582m USD | Total Return: -33.1% in 12m
Warehousing, Storage, Logistics, Cold Chain
Total Rating 28
Safety 48
Buy Signal -0.71
REIT - Industrial
Industry Rotation: -4.5
Industry Rotation: -4.5
Market Cap:
8.58B
Avg Turnover: 30.9M USD
Avg Turnover: 30.9M USD
ATR:
4.07%
Peers RS (IBD): 15.0
Peers RS (IBD): 15.0
Risk 5d forecast
Volatility35.2%
Rel. Tail Risk-6.16%
Reward TTM
Sharpe Ratio-0.96
Alpha-42.51
Character TTM
Beta0.365
Beta Downside0.021
Drawdowns 3y
Max DD61.74%
CAGR/Max DD-0.57
EPS (Earnings per Share)
EPS CAGR: 20.60%
EPS Trend: 59.2%
EPS Trend: 59.2%
Last SUE: 1.06
Qual. Beats: 1
Qual. Beats: 1
Revenue
Rev. CAGR: 0.07%
Rev. Trend: 17.6%
Rev. Trend: 17.6%
Last SUE: -1.33
Qual. Beats: 0
Qual. Beats: 0
Warnings
High Debt/EBITDA (6.2) with thin interest coverage (0.8)
Interest Coverage Ratio 0.8 is critical
Altman Z'' -0.61 < 1.0 - financial distress zone
Choppy
Tailwinds
No distinct edge detected
Description: LINE Lineage, Common Stock
Lineage, Inc. (LINE) is a global real estate investment trust (REIT) specializing in temperature-controlled warehousing. The company operates over 485 facilities across North America, Europe, and Asia-Pacific, encompassing approximately 88 million square feet.
Lineages business model involves providing cold storage and supply chain solutions primarily to food and beverage companies. Industrial REITs, like Lineage, generate revenue through leasing properties and often benefit from long-term contracts. The cold chain logistics sector is crucial for maintaining food safety and reducing spoilage.
Formed in 2015 and based in Novi, Michigan, Lineage, Inc. functions as a subsidiary of BG Lineage Holdings, LLC. To further your understanding of Lineage, Inc.s financial performance and market position, consider exploring its detailed analytics on ValueRay.
- Global food demand growth increases cold storage necessity
- Energy price fluctuations impact operating costs
- Supply chain disruptions boost cold storage demand
- Interest rate hikes affect REIT valuations
- Regulatory changes in food safety create compliance costs
Piotroski VR‑10 (Strict)
3.0
| Net Income: -100.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.96 > 1.0 |
| NWC/Revenue: -5.77% < 20% (prev -3.90%; Δ -1.88% < -1%) |
| CFO/TA 0.05 > 3% & CFO 943.0m > Net Income -100.0m |
| Net Debt (8.59b) to EBITDA (1.38b): 6.22 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (228.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 15.42% > 18% (prev 0.33%; Δ 1.51k% > 0.5%) |
| Asset Turnover: 28.30% > 50% (prev 28.62%; Δ -0.32% > 0%) |
| Interest Coverage Ratio: 0.79 > 6 (EBITDA TTM 1.38b / Interest Expense TTM 616.0m) |
Altman Z''
-0.61
| A: -0.02 (Total Current Assets 1.24b - Total Current Liabilities 1.55b) / Total Assets 19.18b |
| B: -0.13 (Retained Earnings -2.44b / Total Assets 19.18b) |
| C: 0.03 (EBIT TTM 487.0m / Avg Total Assets 18.92b) |
| D: -0.25 (Book Value of Equity -2.53b / Total Liabilities 9.94b) |
| Altman-Z'' Score: -0.61 = B |
Beneish M
-1.99
| DSRI: 1.08 (Receivables 896.0m/826.0m, Revenue 5.36b/5.34b) |
| GMI: 2.14 (GM 15.42% / 33.00%) |
| AQI: 0.98 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.00 (Revenue 5.36b / 5.34b) |
| TATA: -0.05 (NI -100.0m - CFO 943.0m) / TA 19.18b) |
| Beneish M-Score: -1.99 (Cap -4..+1) = B |
What is the price of LINE shares?
As of April 13, 2026, the stock is trading at USD 34.33 with a total of 478,302 shares traded.
Over the past week, the price has changed by +5.27%, over one month by -5.30%, over three months by -6.12% and over the past year by -33.06%.
Over the past week, the price has changed by +5.27%, over one month by -5.30%, over three months by -6.12% and over the past year by -33.06%.
Is LINE a buy, sell or hold?
Lineage, Common Stock has received a consensus analysts rating of 3.63.
Therefor, it is recommend to hold LINE.
- StrongBuy: 4
- Buy: 5
- Hold: 9
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the LINE price?
| Analysts Target Price | 41.4 | 20.5% |
Lineage, Common Stock (LINE) - Fundamental Data Overview
as of 10 April 2026
P/E Forward = 714.2857 P/S = 1.6025
P/B = 0.9072
Revenue TTM = 5.36b USD
EBIT TTM = 487.0m USD
EBITDA TTM = 1.38b USD
Long Term Debt = 6.11b USD (from longTermDebt, last quarter)
Short Term Debt = 136.0m USD (from shortTermDebt, last quarter)
Debt = 8.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.59b USD (from netDebt column, last quarter)
Enterprise Value = 17.17b USD (8.58b + Debt 8.66b - CCE 66.0m)
Interest Coverage Ratio = 0.79 (Ebit TTM 487.0m / Interest Expense TTM 616.0m)
EV/FCF = 87.62x (Enterprise Value 17.17b / FCF TTM 196.0m)
FCF Yield = 1.14% (FCF TTM 196.0m / Enterprise Value 17.17b)
FCF Margin = 3.66% (FCF TTM 196.0m / Revenue TTM 5.36b)
Net Margin = -1.87% (Net Income TTM -100.0m / Revenue TTM 5.36b)
Gross Margin = 15.42% ((Revenue TTM 5.36b - Cost of Revenue TTM 4.53b) / Revenue TTM)
Gross Margin QoQ = -34.81% (prev 32.32%)
Tobins Q-Ratio = 0.90 (Enterprise Value 17.17b / Total Assets 19.18b)
Interest Expense / Debt = 4.14% (Interest Expense 358.0m / Debt 8.66b)
Taxrate = 21.0% (US default 21%)
NOPAT = 384.7m (EBIT 487.0m * (1 - 21.00%))
Current Ratio = 0.80 (Total Current Assets 1.24b / Total Current Liabilities 1.55b)
Debt / Equity = 1.05 (Debt 8.66b / totalStockholderEquity, last quarter 8.25b)
Debt / EBITDA = 6.22 (Net Debt 8.59b / EBITDA 1.38b)
Debt / FCF = 43.83 (Net Debt 8.59b / FCF TTM 196.0m)
Total Stockholder Equity = 8.46b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.53% (Net Income -100.0m / Total Assets 19.18b)
RoE = -1.18% (Net Income TTM -100.0m / Total Stockholder Equity 8.46b)
RoCE = 3.34% (EBIT 487.0m / Capital Employed (Equity 8.46b + L.T.Debt 6.11b))
RoIC = 2.71% (NOPAT 384.7m / Invested Capital 14.21b)
WACC = 5.26% (E(8.58b)/V(17.24b) * Re(7.27%) + D(8.66b)/V(17.24b) * Rd(4.14%) * (1-Tc(0.21)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 81.65 | Cagr: 4.07%
[DCF] Terminal Value 84.51% ; FCFF base≈122.4m ; Y1≈103.7m ; Y5≈79.0m
[DCF] Fair Price = N/A (negative equity: EV 2.40b - Net Debt 8.59b = -6.19b; debt exceeds intrinsic value)
EPS Correlation: 59.15 | EPS CAGR: 20.60% | SUE: 1.06 | # QB: 1
Revenue Correlation: 17.56 | Revenue CAGR: 0.07% | SUE: -1.33 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.15 | Chg7d=+0.000 | Chg30d=+0.018 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=-0.70 | Chg7d=+0.000 | Chg30d=+0.040 | Revisions Net=+1 | Growth EPS=-475.7% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=-0.76 | Chg7d=+0.000 | Chg30d=-0.018 | Revisions Net=+1 | Growth EPS=-7.9% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
External Resources